Patient Administrative Burden in Cancer Care Delivery
癌症护理中的患者行政负担
基本信息
- 批准号:10580183
- 负责人:
- 金额:$ 14.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAntineoplastic AgentsArchitectureCaregiversCaringCharacteristicsClinicalCommunitiesComplementComplexComprehensive Cancer CenterDataDedicationsDevelopmentDiagnosisDoctor of PhilosophyEducationEmergency department visitEquityFailureFinancial costFocus GroupsFutureGoalsGuidelinesHealthHealth PolicyHealth Services AccessibilityHealth systemHealthcare SystemsHospitalizationInequityKnowledgeLinkLow incomeMalignant NeoplasmsManaged CareMeasurementMeasuresMentorsMethodsModalityOncologyOralOutcomePatientsPersonsPharmacy facilityPhasePoliciesPolicy MakerPrevalenceProcessPropertyProxyPsychometricsQuality of CareRecommendationRecurrent Malignant NeoplasmReportingResearchResearch PersonnelRespondentRoleServicesSiteStressSupportive careSurvey MethodologySurveysTimeTrainingValidationWorkcancer carecancer recurrencecancer therapycare coordinationcare deliverycare outcomescareer developmentchemotherapycostdata repositorydesignhealth disparityhigh riskimprovedinformal caregivinginnovationinsightmarginalizationmarginalized populationmedication compliancenoveloutreachpatient engagementprogramsrecruitrepositoryresponsesuccesstheories
项目摘要
PROJECT SUMMARY/ABSTRACT
The US health care system leads the world in administrative complexity and its associated costs. Research on
administrative costs has primarily focused on costs to the health care system and rarely includes patients,
though patients often perform a lot of administrative work, meaning the time, effort, and stress of navigating the
health system to obtain, pay for, and coordinate care. Cancer is a complex and often high-acuity condition with
persistent disparities in health outcomes, making cancer care delivery a priority setting for assessing patient
administrative burdens and identifying solutions. This program of research harnesses multiple methods to
define, measure, and describe the impact of patient administrative burden in cancer care delivery on quality
and care outcomes including oral anticancer agent adherence and guideline-recommended supportive care.
This early K99/R00 will establish Michael Anne Kyle, PhD, RN as an independent investigator focused on
improving the quality and value of cancer care delivery by reducing nonfinancial costs. Training goals in
advanced survey and psychometric methods and cancer care delivery will support Dr. Kyle’s success in her
research aims and transition to independence. An outstanding team of mentors will guide her training and
career development. The K99 phase focuses on defining patient administrative burden in cancer care delivery
and developing a survey instrument to measure it. It will engage patients or patient proxies in focus groups
elucidating the patient-facing nonclinical tasks involved in managing cancer care (Aim 1a). Qualitative insights
will inform the development and validation of a novel survey instrument measuring patient administrative
burden and its psychometric properties (Aim 1b). The R00 phase, will administer the validated patient
administrative burden survey to patients with cancer across a large NCI Comprehensive Cancer Center (Aim
2a). It will then link patient survey data with data on practice characteristics to examine the relationship
between organizational characteristics and administrative burden. (Aim 2b). Finally, it will link the survey with
patient-level utilization data burden to examine the relationship between administrative burden and cancer care
quality, including adherence to oral anticancer agents and adherence to guideline-recommended supportive
care (Aim 2c). Together, these results will enable the measurement and diagnosis of administrative burden
across cancer care settings and produce evidence identifying and motivating actionable organizational or
policy targets for clinical leaders and policymakers.
项目总结/摘要
美国医疗保健系统在行政复杂性及其相关成本方面领先世界。研究
行政成本主要集中在卫生保健系统的成本上,很少包括病人,
虽然患者经常执行大量的行政工作,这意味着时间,努力,以及导航的压力,
卫生系统获得,支付和协调护理。癌症是一种复杂且通常高敏度的疾病,
健康结果的持续差异,使癌症护理服务成为评估患者的优先事项
行政负担和确定解决办法。这项研究计划利用多种方法,
定义、测量和描述癌症护理提供中患者管理负担对质量的影响
和护理结果,包括口服抗癌药依从性和指南推荐的支持性护理。
这个早期的K99/R 00将建立迈克尔安妮凯尔,博士,注册护士作为一个独立的调查员,重点是
通过降低非财务成本来提高癌症护理的质量和价值。培训目标
先进的调查和心理测量方法和癌症护理提供将支持博士凯尔的成功,她在她的
研究目标和向独立的过渡。一个优秀的导师团队将指导她的培训,
职业发展。K99阶段的重点是确定癌症护理提供中的患者管理负担
并开发一种调查工具来衡量它。它将让患者或患者代理人参加焦点小组
阐明癌症护理管理中涉及的面向患者的非临床任务(目标1a)。定性见解
将告知一种新的测量患者管理的调查工具的开发和验证,
负担及其心理测量特性(目标1b)。R 00阶段,将给予经确认的患者
对NCI大型综合癌症中心(Aim)癌症患者的行政负担调查
2a)。然后,它将把病人调查数据与实践特征数据联系起来,以检查这种关系
组织特征与行政负担之间的关系。(Aim 2b)。最后,它将把调查与
患者水平的利用数据负担,以检查行政负担和癌症护理之间的关系
质量,包括对口服抗癌药的依从性和对指南推荐的支持性治疗的依从性
护理(目标2c)。这些结果将有助于衡量和诊断行政负担
在癌症护理环境中,并提供证据,确定和激励可采取行动的组织或
临床领导者和决策者的政策目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Anne Kyle其他文献
Michael Anne Kyle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 14.76万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 14.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 14.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 14.76万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 14.76万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 14.76万 - 项目类别: